What is the recommended dosing frequency for intramuscular (IM) Toradol (Ketorolac) for pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing Frequency for IM Toradol (Ketorolac)

IM ketorolac should be administered no more frequently than every 6 hours, with a maximum daily dose of 120 mg for patients under 65 years and 60 mg for patients 65 years or older, and treatment duration must not exceed 5 days. 1

Dosing Guidelines

Standard Dosing Regimen

  • Patients <65 years of age:

    • 30 mg IM every 6 hours
    • Maximum daily dose: 120 mg 1
  • Patients ≥65 years, renally impaired, or <50 kg (110 lbs):

    • 15 mg IM every 6 hours
    • Maximum daily dose: 60 mg 1

Single-Dose Treatment

  • Patients <65 years of age:

    • One dose of 60 mg IM 1
  • Patients ≥65 years, renally impaired, or <50 kg (110 lbs):

    • One dose of 30 mg IM 1

Important Considerations

Duration Limitations

  • Treatment with ketorolac must not exceed 5 days total 1
  • This strict limitation is critical to minimize risk of serious adverse effects

Pharmacokinetics

  • Onset of analgesic effect: ~30 minutes
  • Maximum effect: 1-2 hours after administration
  • Duration of analgesic effect: 4-6 hours 1

Contraindications

  • Aspirin/NSAID-induced asthma
  • Pregnancy
  • Cerebrovascular hemorrhage
  • Hypovolemia (must be corrected prior to administration) 2, 1

Common Adverse Effects

  • Edema
  • Drowsiness
  • Dizziness
  • GI upset
  • Increased diaphoresis 2

Clinical Pearls and Pitfalls

Important Warnings

  • Never exceed 5 days of treatment - this is a strict limitation to prevent serious adverse effects
  • Do not administer concurrently with other NSAIDs
  • Avoid in patients with renal impairment, active peptic ulcer disease, or bleeding disorders
  • Correct hypovolemia before administration 1

Administration Technique

  • IM injections should be given slowly and deeply into the muscle 1
  • For breakthrough pain, do not increase the frequency of ketorolac; consider supplementing with low doses of opioids if not contraindicated 1

Compatibility Issues

  • Do not mix ketorolac in a small volume (e.g., in a syringe) with morphine sulfate, meperidine hydrochloride, promethazine hydrochloride, or hydroxyzine hydrochloride as this will cause precipitation 1

By adhering to these dosing guidelines and precautions, ketorolac can provide effective pain management while minimizing the risk of adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.